Home / Markets / IPO / Top headlines: Dr Reddy's Q1 PAT up 108%; Adani Capital IPO likely in 2024

Top headlines: Dr Reddy's Q1 PAT up 108%; Adani Capital IPO likely in 2024

Bajaj Finserv on Thursday reported a 57 per cent jump in net profit at Rs 1,309 crore in the first quarter ended June 30, on healthy earnings by its subsidiary companies.

Premium

Dr Reddy's revenues during the quarter under discussion were up by six per cent to Rs 5,215.4 crore compared to Rs 4,919.4 crore in the first quarter of FY22.

BS Web Team New Delhi

2 min read Last Updated : Jul 28 2022 | 6:00 PM IST

Dr Reddy's Q1 PAT soars 108% to Rs 1,188 cr; revenue rises 6%

Backed by a substantial rise in other income, Dr Reddy's Laboratories Ltd on Thursday said its consolidated profit after tax (PAT) for the quarter ended June 30, 2022 was up by 108 per cent at Rs 1187.6 crore against Rs 570.8 crore in the same quarter a year ago.

Revenues during the quarter under discussion were up by six per cent to Rs 5,215.4 crore compared to Rs 4,919.4 crore in the first quarter of FY22. Read more

Adani Capital planning IPO as soon

Topics : Dr Reddy's Laboratories Adani capital IPOs Bajaj Finserv Aviation industry US airlines

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in